Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.

Publication Type:

Journal Article

Source:

Cancer (2014)

Keywords:

2014, Clinical Research Division, July 2014

Abstract:

The importance of human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive marker in invasive breast cancer is well established. Accurate assessment of HER2 status is essential to determine optimal treatment options.